Shareholding disclosure

Imperial Fund Ltd

Declared position

5.3%

Threshold

Crossed upwards

Timeline

Published

30.09.2011

Transaction

20.09.2011

Voting rights breakdown

Voting rights acquired5.3%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAB9S00053

Beneficial owner

Imperial Fund Ltd

Declared address

Imperial Fund Ltd, P.O. Box 30745 Grand Cayman, KY11-1203

Change in company's registered capital. Stock split 10 for 1.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Imperial Fund Ltd

MindMaze Therapeutics Holding SA30.09.2011TAB9S00053

Disclosure summary

Imperial Fund Ltd disclosed a holding in MindMaze Therapeutics Holding SA on the acquisition side, published by SIX Exchange Regulation on 30.09.2011, at 5.3% of voting rights. Notice category: Single shareholder.

Disclosed position

5.3%

Voting rights acquired

Voting rights acquired5.3%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Imperial Fund Ltd disclosed a holding in MindMaze Therapeutics Holding SA, published on 30.09.2011.

Publication date30.09.2011

Transaction date20.09.2011

Issuing companyMindMaze Therapeutics Holding SA

Beneficial ownerImperial Fund Ltd

Declared addressImperial Fund Ltd, P.O. Box 30745 Grand Cayman, KY11-1203

CategorySingle shareholder

Voting rights acquired5.3%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAB9S00053

Conditions

Change in company's registered capital. Stock split 10 for 1.

Source: SIX Exchange Regulation · Publication date: 30.09.2011

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open